These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 16259218

  • 21. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [Abstract] [Full Text] [Related]

  • 22. Exendin-4 protects beta-cells from interleukin-1 beta-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway.
    Ferdaoussi M, Abdelli S, Yang JY, Cornu M, Niederhauser G, Favre D, Widmann C, Regazzi R, Thorens B, Waeber G, Abderrahmani A.
    Diabetes; 2008 May; 57(5):1205-15. PubMed ID: 18252896
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Therapeutic promise of JNK ATP-noncompetitive inhibitors.
    Bogoyevitch MA.
    Trends Mol Med; 2005 May; 11(5):232-9. PubMed ID: 15882611
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Unraveling the molecular mechanisms behind the metabolic basis of sporadic Alzheimer's disease.
    Erol A.
    J Alzheimers Dis; 2009 May; 17(2):267-76. PubMed ID: 19221404
    [Abstract] [Full Text] [Related]

  • 28. Inflammatory pathways and insulin action.
    Hotamisligil GS.
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S53-5. PubMed ID: 14704746
    [Abstract] [Full Text] [Related]

  • 29. Design, synthesis, and biological activity of novel, potent, and selective (benzoylaminomethyl)thiophene sulfonamide inhibitors of c-Jun-N-terminal kinase.
    Rückle T, Biamonte M, Grippi-Vallotton T, Arkinstall S, Cambet Y, Camps M, Chabert C, Church DJ, Halazy S, Jiang X, Martinou I, Nichols A, Sauer W, Gotteland JP.
    J Med Chem; 2004 Dec 30; 47(27):6921-34. PubMed ID: 15615541
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Targeting the JNK signaling pathway for stroke and Parkinson's diseases therapy.
    Kuan CY, Burke RE.
    Curr Drug Targets CNS Neurol Disord; 2005 Feb 30; 4(1):63-7. PubMed ID: 15723614
    [Abstract] [Full Text] [Related]

  • 32. JNK at the crossroad of obesity, insulin resistance, and cell stress response.
    Solinas G, Becattini B.
    Mol Metab; 2017 Feb 30; 6(2):174-184. PubMed ID: 28180059
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Inflammation and endoplasmic reticulum stress in obesity and diabetes.
    Hotamisligil GS.
    Int J Obes (Lond); 2008 Dec 30; 32 Suppl 7(Suppl 7):S52-4. PubMed ID: 19136991
    [Abstract] [Full Text] [Related]

  • 37. Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes.
    Yung JHM, Giacca A.
    Cells; 2020 Mar 13; 9(3):. PubMed ID: 32183037
    [Abstract] [Full Text] [Related]

  • 38. JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases.
    Kumar A, Singh UK, Kini SG, Garg V, Agrawal S, Tomar PK, Pathak P, Chaudhary A, Gupta P, Malik A.
    Future Med Chem; 2015 Mar 13; 7(15):2065-86. PubMed ID: 26505831
    [Abstract] [Full Text] [Related]

  • 39. A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity.
    Vallerie SN, Furuhashi M, Fucho R, Hotamisligil GS.
    PLoS One; 2008 Sep 05; 3(9):e3151. PubMed ID: 18773087
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.